 SAN CARLOS, Calif., Oct. 06, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA, a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular diseases, today announced it will be participating in the A.G.P Biotech Specialty Pharma Conference taking place virtually on October 13, 2021. 